Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012) [Phase 3]
A Phase 3 trial (LEAP-012) evaluating lenvatinib plus pembrolizumab with transarterial chemoembolization in patients with incurable/non-meta…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI [NA]
A clinical trial comparing ultrasound versus MRI imaging to prevent liver cancer mortality in people with hepatocellular carcinoma or cirrho…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer [Phase 1]
Phase 1 clinical trial evaluating the combination of durvalumab and tremelimumab after radioembolization for unresectable locally advanced h…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Efficacy and Safety Comparison Between PD-1 Inhibitor Combined With Lenvatinib or With Regorafenib For UHCC After Failure of First-line Treatment [NA]
A completed clinical trial comparing a PD-1 inhibitor plus lenvatinib versus a PD-1 inhibitor plus regorafenib in patients with unresectable…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis [Phase 2]
A Phase II trial testing moderate-dose hypofractionated radiotherapy plus tislelizumab for hepatocellular carcinoma with diffuse tumor throm…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC
This clinical trials update reports on a completed study evaluating transarterial chemoembolization (TACE) in combination with PD-1/PD-L1 in…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC
A clinical trial evaluating transarterial chemoembolization (TACE) in combination with PD-1/PD-L1 inhibitors and molecular-targeted therapie…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer [Phase 1]
A first-in-human Phase 1 study to evaluate the safety and initial activity of BAY 3547926 in adults with advanced hepatocellular carcinoma. …
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma [Phase 1, Phase 2]
The clinical trial of T-ACE Oil for hepatocellular carcinoma (Phase 1/Phase 2) is currently suspended.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC [Phase 3]
A Phase 3 trial evaluated interferon-free regimens for patients with chronic hepatitis C who had been successfully treated for hepatocellula…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Enhanced Radiofrequency Ablation for Recurrent HCC Post-TACE Using Twin Internally Cooled-Perfusion Electrodes [NA]
A completed clinical trial evaluating enhanced radiofrequency ablation using twin internally cooled-perfusion electrodes for recurrent hepat…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma [NA]
This ClinicalTrials.gov update reports on the completed feasibility study of microwave ablation using a two-channel microwave generator and …
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 1 Study of the Safety and Tolerability of CTX-10726 [Phase 1]
Phase 1 study update on the safety and tolerability of CTX-10726, currently recruiting across gastroesophageal cancer, hepatocellular carcin…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis [Phase 3]
A Phase 3 trial evaluating Lipiocis as adjuvant treatment for hepatocellular carcinoma has completed; sponsor information includes ANRS and …
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
ClinicalTrials.gov entry for an exosome-based liquid biopsy to differentiate hepatocellular carcinoma from intrahepatic cholangiocarcinoma, …
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma [Phase 3]
Phase 3 trial comparing transarterial chemoembolization plus radiofrequency ablation versus TACE alone in intermediate-stage hepatocellular …
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion [Phase 2]
Phase 2 trial evaluating hepatic arterial idarubicin with lipiodol emulsion for hepatocellular carcinoma in cirrhosis; the study (NCT0372763…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 dose-escalation trial of regorafenib in advanced hepatocellular carcinoma is ongoing but not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Development of a Neuronal Microscope [NA]
Clinical trial NCT06311396, sponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, titled 'Development of a Neuronal Micro…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC [Phase 2]
This Phase 2 trial evaluates WGI-0301 in combination with nivolumab in patients with hepatocellular carcinoma and renal cell carcinoma. The …
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Lenvatinib or Regorafenib for Advanced Hepatocellular Carcinoma After Immunotherapy (REVIVE) [Phase 2]
This is a Phase 2 clinical trial (REVIVE) evaluating lenvatinib or regorafenib for advanced hepatocellular carcinoma after immunotherapy; th…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Ultra-stable Iodized Oil-Chemo Embolization Seq Thermal Ablation in Early Liver Ca [NA]
Clinical trial update for NCT07493070 evaluating ultra-stable iodized oil chemoembolization followed by sequential thermal ablation in early…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres
A completed clinical trial assessed selective flex-dosing using Y-90 SIR-Spheres for unresectable hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor [Phase 1, Phase 2]
This entry provides a status update on a phase 1/2 study of Eisai's E7386 in combination with other anticancer drugs for solid tumors. The t…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC) [Phase 2]
A phase 2 study evaluating pembrolizumab in combination with local tumor ablation for hepatocellular carcinoma has completed and posted resu…